LETTER
Synthesis of 3-Imidazolyl 1,2,4-Triazoles and 1,2,4-Oxadiazolones
2795
(8) Borg, S.; Vollinga, R. C.; Labarre, M.; Payza, K.; Terenius,
L.; Luthman, K. J. Med. Chem. 1999, 42, 4331.
(15) General Procedure for the Synthesis of 1,2,4-
Oxadiazolones 4
(9) (a) Yeung, K.-S.; Farkas, M. E.; Kadow, J. F.; Meanwell,
N. A. Tetrahedron Lett. 2005, 46, 3429. (b) Amarasinghe,
K. K. D.; Maier, M. B.; Srivastavab, A.; Graya, J. L.
Tetrahedron Lett. 2006, 47, 3629. (c) Katritzky, A. R.;
Khashab, N. M.; Kirichenko, N.; Singh, A. J. Org. Chem.
2006, 71, 9051. (d) Bibian, M.; Blayo, A.-L.; Moulin, A.;
Martinez, J.; Fehrentz, J.-A. Tetrahedron Lett. 2010, 51,
2660.
(10) (a) Su, Y.; Jiang, Z.; Hong, D.; Lu, P.; Wang, Y.; Lin, X.
Tetrahedron 2010, 66, 2427. (b) Kurz, T.; Lolak, N.;
Geffken, D. Tetrahedron Lett. 2007, 48, 2733. (c) Yin, P.;
Ma, W.-B.; Chen, Y.; Huang, W.-C.; Deng, Y.; He, L. Org.
Lett. 2009, 11, 5482. (d) Ueda, S.; Nagasawa, H. J. Am.
Chem. Soc. 2009, 131, 15080. (e) Wang, Y.; Miller, R. L.;
Sauer, D. R.; Djuric, S. W. Org. Lett. 2005, 7, 925. (f) Lin,
S.; Lang, J. r. Y.-iA.; Lovell, M. F.; Perkinson, N. A. J. Org.
Chem. 1979, 44, 4160. (g) Saleem, R. S. Z.; Tepe, J. J.
J. Org. Chem. 2010, 75, 4330. (h) Perez, M. A.; Dorado,
C. A.; Soto, J. L. Synthesis 1983, 483.
A yellow suspension of 2 (0.29–1.85 mmol) in CH2Cl2 (for
4a, 15.0 mL) or in MeCN (for 4b–d, 3.0–5.0 mL) was added
to a solution of hydroxylamine hydrochloride (for 4a, 3.0
equiv; for 4b–d, 2.0 equiv; for 4c, 1.2 equiv) in aq 1 M KOH
(for 4a, 3.0 equiv) or to a solution of Et3N (for 4b–d, 3.0
equiv) in MeCN. The mixture was stirred at r.t., and after
29–72 h the starting material was totally consumed. The
light yellow solid was filtered and washed with EtOH,
MeCN, and Et2O to give compounds 4 in 17–99% yield. The
structure of the products was confirmed by elemental
analysis, 1H NMR and 13C NMR spectroscopy.
3-[5-Amino-1-(4-methoxyphenyl)-1H-imidazol-4-yl]-
1,2,4-oxadiazol-5 (4H)-one (4a)
Mp 261–264 °C. 1H NMR (300 MHz, DMSO-d6):
d = 13.00–10.00 (br s, 1 H), 7.49 (s, 1 H), 7.42 (d, J = 8.7 Hz,
2 H), 7.11 (d, J = 8.7 Hz, 2 H), 5.46 (s, 2 H), 3.81 (s, 3 H).
13C NMR (75 MHz, DMSO-d6): d = 159.54, 159.30, 155.30,
140.73, 132.66, 126.78, 126.75, 114.96, 103.15, 55.56.
Anal. Calcd for C12H11N5O3: C, 52.75; H, 4.06; N, 25.63.
Found: C, 52.85; H, 4.13; N, 25.57. IR (mull): 3414, 3317,
3128, 1787 (CO), 1633 cm–1.
(11) (a) Temple, C. Jr.; Kussner, C. L.; Montgomery, J. A. J. Org.
Chem. 1965, 30, 3601. (b) Temple, C. Jr.; Kussner, C. L.;
Montgomery, J. A. J. Org. Chem. 1967, 32, 2241.
(c) Okamura, T.; Kurogi, Y. J. Med. Chem. 2002, 45, 3703.
(d) Hosmane, R. S.; Lim, B. B.; Burnett, F. N. J. Org. Chem.
1988, 53, 382.
(16) General Procedure for the Synthesis of 5
A suspension of aminopiperidine or 1-amino-4-
metilpiperazine (1.2–1.3 equiv) and imidazole 2 (0.98–1.20
mmol) in CH2Cl2 (0.5 mL) or EtOH (2.0 mL) was stirred at
r.t.. After 45–50 min the yellow suspension evolved to a
white solid precipitate that was filtered and washed with
EtOH and Et2O. The structure of the products obtained was
confirmed by elemental analysis, 1H NMR and 13C NMR
spectroscopy.
Ethyl [5-Amino-1-(4-methoxyphenyl)-1H-imidazol-4-
yl](piperidin-1-ylimino)methylcarbamate (5a)
Mp 165–166 °C. 1H NMR (300 MHz, DMSO-d6): d = 8.06
(s, 1 H), 7.38 (d, J = 8.7 Hz, 2 H) 7.38 (s, 1 H), 7.10 (d,
J = 8.7 Hz, 2 H), 5.69 (br s, 2 H), 3.81 (s, 3 H), 3.98 (q,
J = 7.2 Hz, 2 H), 2.50–3.50 (br s, 4 H), 1.50 (br s, 6 H), 1.20
(t, J = 7.2 Hz, 3 H). 13C NMR (75 MHz, DMSO-d6):
d = 162.35, 159.04, 149.28, 141.60, 130.05, 59.95, 55.55,
55.03, 26.69, 25.27, 14.28. Anal. Calcd for C19H26N6O3: C,
59.05; H, 6.78; N, 21.75. Found: C, 59.08; H, 6.68; N, 21.69.
IR (mull): 3359, 3287, 3162, 3112, 3066, 1698 (CO), 1618,
1571 cm–1.
(12) (a) Alves, M. J.; Booth, B. L.; Freitas, A. P.; Proença, M. F.
J. Chem. Soc., Perkin Trans. 1 1992, 913. (b) Booth, B. L.;
Dias, A. M.; Proença, M. F. J. Chem. Soc., Perkin Trans. 1
1992, 2119. (c) Alves, M. J.; Booth, B. L.; Proença, M. F.
J. Heterocycl. Chem. 1994, 31, 345. (d) Booth, B. L.;
Coster, R. D.; Proença, M. F. Synthesis 1988, 389.
(e) Alves, M. J.; Booth, B. L.; Carvalho, M. A.; Pritchar d,
R. G.; Proença, M. F. J. Heterocycl. Chem. 1997, 739.
(f) Al-Azmi, A.; Booth, B. L.; Carpenter, R. A.; Carvalho,
M. A.; Marrelec, E.; Pritchard, R. G.; Proença, M. F. J.
Chem. Soc., Perkin Trans. 1 2001, 2532. (g) Booth, B. L.;
Cabral, I. M.; Dias, A. M.; Freitas, A. P.; Matos-Beja, A. M.;
Proença, M. F.; Ramos-Silva, M. J. Chem. Soc., Perkin
Trans. 1 2001, 1241. (h) Carvalho, M. A.; Esteves, T. M.;
Proença, M. F.; Booth, B. L. Org. Biomol. Chem. 2004, 2,
1019. (i) Carvalho, M. A.; Álvares, Y.; Zaki, M. E.; Proença,
M. F.; Booth, B. L. Org. Biomol. Chem. 2004, 2, 2340.
(13) Dias, A. M.; Cabral, I. M.; Vila-Chã, A. S.; Proença, M. F.
Synlett 2007, 1231.
(17) General Procedure for the Synthesis of 6 and 7
Acetic or benzoic anhydride (2.0 equiv) was added to a
suspension of 1 (1.0–4.0 mmol) in MeCN (1.0–5.0 mL) at 0
°C, and the mixture was stirred at r.t. until the starting
material was totally consumed (2–4 h). The bright yellow/
orange solid was filtered and washed with MeCN and Et2O
to give compounds 6 and 7 in 13–99% yields. The structure
of the products was confirmed by elemental analysis, 1H
NMR and 13C NMR spectroscopy.
5-Amino-1-(4¢-fluorophenyl)-4-[(N-benzoyl)cyano-
formimidoyl]-1H-imidazole (7, R1 = 4-FC6H4, R2 = Ph)
Mp 167–168 °C. 1H NMR (300 MHz, DMSO-d6): d = 8.34
(br s, 2 H), 8.08 (d, J = 7.2 Hz, 2 H), 7.77 (s, 1 H), 7.64 (t,
J = 7.2 Hz, 1 H), 7.55 (dd, J = 9.0, 4.8 Hz, 2 H), 7.54 (t,
J = 7.2 Hz, 2 H), 7.44 (t, J = 9.0 Hz, 1 H). 13C NMR (75
MHz, DMSO-d6): d = 174.93, 160.06 (d, J = 243 Hz),
151.23, 138.60, 135.38, 134.74, 132.81, 131.57 (d, J = 3
Hz), 129.41, 128.51, 125.08 (d, J = 8 Hz), 122.51, 116.31 (d,
J = 22 Hz), 112.14. Anal. Calcd for C12H11N5O3·0.1H2O: C,
64.51; H, 3.67; N, 20.90. Found: C, 64.40; H, 3.81; N, 20.86.
IR (mull): 3342, 2232 (CN), 1629, 1603, 1529 cm–1.
(18) General Procedure for the Synthesis of 8 and 9
Hydrazine monohydrate (2.0 or 1.2 equiv) was added to a
(14) General Procedure for the Synthesis of 1,2,4-Triazolones
3
Hydrazine monohydrate (2.0 equiv) was added to a
suspension of imidazole 2 (0.52–1.95 mmol) in DMF (for 3a
and 3b, 2.0 mL) or EtOH (for 3c–f, 1.0–5.0 mL). The
mixture was stirred at r.t. for 5–30 min (for 3a,b and 3d–e),
and at 0 °C for 40 min (for 3c and 3f). The resulting
suspension was filtered and washed with EtOH and Et2O to
give compounds 3 (78–99%). The structure of the products
was confirmed by elemental analysis, 1H NMR and 13
NMR spectroscopy.
C
5-[5-Amino-1-(4-methoxyphenyl)-1H-imidazol-4-yl]-2,4-
dihydro-3H-1,2,4-triazol-3-one (3a)
Mp >316 °C (dec.). 1H NMR (300 MHz, DMSO-d6):
d = 11.20 (s, 1 H), 7.42 (d, J = 8.7 Hz, 2 H), 7.39 (s, 1 H),
7.09 (d, J = 8.7 Hz, 2 H), 5.22 (s, 2 H), 3.81 (s, 3 H). 13
C
NMR (75 MHz, DMSO-d6): d = 158.98, 155.64, 144.33,
137.91, 130.96, 127.36, 126.31, 114.85, 108.10, 55.52.
Anal. Calcd for C12H12N6O2: C, 52.94; H, 4.44; N, 30.87.
Found: C, 52.75; H, 4.60; N, 30.88. IR (mull): 3428, 3331,
3102, 1715 (CO), 1634 cm–1.
Synlett 2010, No. 18, 2792–2796 © Thieme Stuttgart · New York